Plain-English translation of NCT06381375 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study—meaning researchers will watch and document what happens to tuberculosis patients who are taking their anti-tuberculosis medications along with other drugs. The goal is to understand how common it is for these medications to interact with each other, and what side effects patients experience. No new or experimental treatment is being tested; instead, researchers are learning from everyday medical care.
Tuberculosis patients often need to take multiple medications at the same time for other health conditions. When drugs are taken together, they can sometimes interact with each other in ways that reduce how well they work or cause unwanted side effects. This study exists to figure out how often these interactions happen and what impact they have on patients, so doctors can better protect patients from harm.
You likely qualify if…
You likely don't qualify if…
You will have an initial visit where the research team collects basic health information, reviews your current medications, and takes blood tests to check your liver function. Over the next month, you'll keep two simple diaries: one to write down any new medications you start taking, and another to track any side effects you notice day by day. The whole study lasts about 6 months, and your participation involves these records and check-ins at your regular clinic visits.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Egypt
Enrollment target
~400 participants
Started
April 2024
Primary completion
December 2024
This trial's estimated completion date has passed — the record may not be fully up to date.
Last updated on clinicaltrials.gov in August 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Omnia Azmy Nabeh, MD
Cairo University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.